| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.884 | 63.087 | 91.969 | 123.138 | 136.974 | 227.392 | 364.676 | 424.364 | 611.322 | 897.091 |
| Total Income - EUR | 30.884 | 63.087 | 91.970 | 123.138 | 136.974 | 238.576 | 364.680 | 424.365 | 611.338 | 897.101 |
| Total Expenses - EUR | 27.391 | 81.425 | 50.766 | 55.259 | 112.933 | 216.599 | 366.493 | 420.601 | 589.347 | 775.475 |
| Gross Profit/Loss - EUR | 3.493 | -18.338 | 41.203 | 67.879 | 24.041 | 21.977 | -1.813 | 3.764 | 21.992 | 121.626 |
| Net Profit/Loss - EUR | 2.566 | -18.969 | 40.283 | 66.647 | 22.671 | 20.039 | -4.775 | 538 | 18.731 | 107.574 |
| Employees | 4 | 3 | 4 | 4 | 5 | 9 | 10 | 10 | 14 | 16 |
Check the financial reports for the company - Clario Oftaclinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 106 | 21 | 0 | 0 | 0 | 0 | 32.014 | 46.738 | 40.314 | 33.155 |
| Current Assets | 5.365 | 5.746 | 26.841 | 92.365 | 121.218 | 152.739 | 143.511 | 165.893 | 189.005 | 244.873 |
| Inventories | 169 | 167 | 164 | 202 | 199 | 195 | 0 | 0 | 0 | 0 |
| Receivables | 3.496 | 3.546 | 13.087 | 44.225 | 59.415 | 88.701 | 118.399 | 147.313 | 168.185 | 182.981 |
| Cash | 1.701 | 2.033 | 13.590 | 47.937 | 61.604 | 63.844 | 25.112 | 18.580 | 20.820 | 61.892 |
| Shareholders Funds | 2.611 | -16.384 | 24.176 | 90.380 | 111.301 | 129.231 | 121.589 | 122.504 | 140.863 | 247.650 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.860 | 22.152 | 2.664 | 1.985 | 9.917 | 14.797 | 47.121 | 67.817 | 82.385 | 24.281 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 8.712 | 6.815 | 22.310 | 6.071 | 6.097 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Clario Oftaclinic Srl